PAX6 is also involved in inhibiting angiogenesis in gliomas, as it is found to downregulate expression of vascular endothelial growth factor A (VEGFA) [21], the main angiogenic factor overexpressed in GBM. Here, VEGFA is linked to central nervous system cancer.